Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents

Clin Immunol. 2021 Dec 27:108912. doi: 10.1016/j.clim.2021.108912. Online ahead of print.ABSTRACTDespite high levels of MMR-II usage in the US, mumps outbreaks continue to occur. Evidence suggests that mumps vaccine-induced humoral immunity wanes over time. Relatively few studies have examined cell-mediated immunity or reported on sex-based differences. To better understand sex-based differences in the immune response to mumps vaccine, we measured neutralizing antibody titers and mumps-specific cytokine/chemokine responses in a cohort of 748 adolescents and young adults after two doses of MMR vaccine. We observed significantly higher neutralizing antibody titers in females than in males (120.8 IU/mL, 98.7 IU/mL, p = 0.038) but significantly higher secretion levels of MIP-1α, MIP-1β, TNFα, IL-6, IFNγ, and IL-1β in males compared to females. These data demonstrate that sex influences mumps-specific humoral and cell-mediated immune response outcomes, a phenomenon that should be considered during efforts to improve vaccines and prevent future outbreaks.PMID:34968746 | DOI:10.1016/j.clim.2021.108912
Source: Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research